Back
Clinuvel Pharmaceuticals 10K Form
Sell
45
CLVLF
Clinuvel Pharmaceuticals
Last Price:
8.45
Seasonality Move:
5.6%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CLVLF News And Ratings
See the #1 stock for the next 7 days that we like better than CLVLF
CLVLF Financial Statistics
Sales & Book Value
| Annual Sales: | $57.81M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.71 |
| Price / Book: | 3.12 |
Profitability
| EPS (TTM): | 0.45840 |
|---|---|
| Net Income (TTM): | $23.4M |
| Gross Margin: | $51.2M |
| Return on Equity: | 19.16% |
| Return on Assets: | 16.45% |
Clinuvel Pharmaceuticals Earnings Forecast
Key Clinuvel Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 20 years for CLVLF is 88.57%.
- The Selling, General & Administrative Expenses for CLVLF have been equal to 28.38% of Gross Profit Margin.
- The Research & Development expenses have been 259.75% of Revenue.
- The Interest Expense is 12.50% of Operating Income.
- The Net Earning history of CLVLF is 40.41% of Total Revenues.
- Per Share Earnings over the last 25 years have been positive in 14 years.
Clinuvel Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CLVLF |
| Website: | clinuvel.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 8.81 |
| Quick Ratio: | 8.33 |
Price-to-Earnings
| Trailing P/E Ratio: | 18.47 |
|---|---|
| Forward P/E Ratio: | 0 |
CLVLF Technical Analysis vs Fundamental Analysis
Sell
45
Clinuvel Pharmaceuticals (CLVLF)
is a Sell
Is Clinuvel Pharmaceuticals a Buy or a Sell?
-
Clinuvel Pharmaceuticals stock is rated a Sell
The current Clinuvel Pharmaceuticals [CLVLF] share price is $8.45. The Score for CLVLF is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.